Not provided
Not provided
Not provided
Not provided
Premature termination due to recruitment difficulties
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| WoundEL Health Care | UNKNOWN |
Not provided
Not provided
Not provided
Several studies have suggested that the endogenous electric field and its polarity stimulate the proliferation and migration of epithelial cells and therefore promote wound healing. WoundEL® will reproduce the endogenous electrical current to stimulate all the factors contributing to healing.
Electrostimulation of wounds, including the WoundEL® device, is a therapy listed but not yet reimbursed in France. The aim of this study is to show that the WoundEL® electrostimulation device is superior to the reference treatments recognized by the HAS.
Patients with a leg ulcer will be randomized to the "usual treatment" or "WoundEL" group.
The progress of the leg ulcer will be monitored every 2 weeks for 8 weeks or sooner if wound healing occurs. All leg ulcers will be examined at 10 weeks to check for healing or the condition of the leg ulcer if it has not healed. A third-blind party will also assess the ulcer condition at 10 weeks, based on standardized photographs.
The consumption of analgesics, pain and quality of life will be compared in the 2 groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Electrical stimulation wound management system | Experimental | Two daily electrostimulation sessions using the WoundEL® device on wound two for 30 minutes at an adjustable intensity, between 5 and 42 milliampere and chosen by the patient. |
|
| Standard of care | Active Comparator | Use of dressings appropriate to the stage of healing according to French recommendations for the management of leg ulcers. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| WoundEL medical device | Device | The WoundEl system is composed by: a class IIa device , a class IIb dressing electrode and a class I disperser electrode. Applied to the leg ulcer, WoundEL® reproduces the endogenous electrical current to stimulate all the factors contributing to healing. Electrical current is evenly spread over the Dressing Electrode which also maintains a moist wound healing environment. |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of healed-leg ulcers | Complete wound-healing correspond to 100% epithelialization of the leg ulcer, without persistent erosion or crusting. Complete healing of ulcers will be observed by the investigator and assessed by a third-blind. | At week 8 |
| Measure | Description | Time Frame |
|---|---|---|
| Assessing the leg ulcer-related pain | Visual Analogic Scale | At weeks 0,2, 4, 6, 8 |
| Assessing the analgesic consumption | Patient reported-consumption of painkillers |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| HERVE MAILLARD, MD | Centre Hospitalier du Mans | Principal Investigator |
| LAURE-CECILE MARTIN | WoundEL Health Care | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier Du Mans | Le Mans | 72037 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007871 | Leg Ulcer |
| D064752 | Atrial Remodeling |
| ID | Term |
|---|---|
| D012883 | Skin Ulcer |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D020763 | Pathological Conditions, Anatomical |
Not provided
Not provided
Superiority randomized controlled study, open label with blinded primary outcome assessor, multicentric
Not provided
Not provided
The third blind person will have photographs of the wound at 10 weeks and all the surface readings on tracing paper necessary for the automated calculation of the surface with specific software. Readings will be sent in random order and third parties will not know the treatment, patient or date of the reading.
|
| Standard cares | Other | Cleaning and monitoring |
|
| At weeks 0,2, 4, 6, 8 |
| Assessing the quality of life | EuroQol (EQ5-D) questionnaire | At weeks 0,2, 4, 6, 8 |
| Assessing the leg ulcer healing stage | Area measurement, periwound skin aspect, local signs of infection, antibiotic rescue | At weeks 0,2, 4, 6, 8, 10 |
| WoundEL system security | Adverse reactions, dysfunctions | At weeks 0,2, 4, 6, 8 |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010335 | Pathologic Processes |